VERONICA ZOLLO: Open Payments
NPI 1306155148 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 12 payments from 10 companies in 2025. Trend: 2023 $318 · 2024 $280 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, AUSTEDO XR, Leqembi, Veozah, TZIELD, VRAYLAR, Ozempic, Symbravo.
Industry payments across OK — which companies pay providers there.
